DEZHAN HEALTHCARE(000813)

Search documents
德展健康(000813) - 2017 Q1 - 季度财报
2017-04-21 16:00
Financial Performance - The company's revenue for Q1 2017 was ¥349,882,314.39, representing a 13.79% increase compared to ¥307,479,066.17 in the same period last year[8] - Net profit attributable to shareholders was ¥162,846,842.28, up 24.53% from ¥130,773,079.59 year-on-year[8] - Basic and diluted earnings per share were both ¥0.11, down 26.67% from ¥0.15 in the same period last year[8] - The total assets at the end of the reporting period were ¥4,111,269,786.15, an increase of 4.69% from ¥3,926,931,218.32 at the end of the previous year[8] - The net assets attributable to shareholders were ¥3,916,152,186.30, reflecting a 4.34% increase from ¥3,753,305,344.02 at the end of the previous year[8] - The weighted average return on equity decreased to 4.25%, down 4.13% from 8.38% in the previous year[8] Cash Flow and Expenses - The net cash flow from operating activities decreased by 65.28%, amounting to ¥31,286,342.28 compared to ¥90,102,263.13 in the previous year[8] - The company reported a significant increase in other receivables, rising by 41.08% to ¥3,884,272.99 compared to ¥2,753,187.62 at the end of 2016[18] - Prepayments decreased by 57.48% to ¥684,066.43, primarily due to the recognition of revenue from previously received prepayments[18] - The company's tax expenses increased by 58.89% to ¥8,562,943.64, attributed to a rise in operating income[18] - Management expenses rose by 40.33% to ¥29,931,966.43, mainly due to increased employee compensation and depreciation costs[18] - Cash flow from operating activities decreased by 65.28% to ¥31,286,342.28, primarily due to increased payments for materials[19] - The net cash increase in cash and cash equivalents was negative at -¥9,475,711.25, a decline of 106.92% compared to the previous year[19] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 23,077[13] - The top shareholder, Meilin Holdings Group, held 29.74% of the shares, amounting to 444,399,114 shares, with a portion pledged[13] Investment and Restructuring - The company completed a major asset restructuring, acquiring 75 million shares of Tianshan Textile, with a lock-up period of 36 months from the date of listing[21] - The company committed to not transferring shares of Tianshan Textile for 12 months after the acquisition, ensuring compliance with relevant securities laws and regulations[22] - The restructuring includes a profit compensation obligation, with 50% of the shares to be unlocked after the first year of fulfilling the obligation[22] - The company aims to avoid unnecessary related transactions with Tianshan Textile post-restructuring, ensuring transparency and fairness in transactions[21] - The company has pledged to protect the interests of Tianshan Textile and its shareholders by adhering to market principles in related transactions[21] - The company will not transfer shares if there are ongoing investigations by judicial authorities or the China Securities Regulatory Commission[22] - The company has established a commitment to lock shares voluntarily for investor compensation arrangements in case of violations found during investigations[22] - The company will ensure timely information disclosure regarding any related transactions to protect shareholder rights[21] - The company has a commitment to avoid related transactions that may harm the interests of Tianshan Textile and its shareholders[21] - The company will follow fair trading principles in any related transactions with Tianshan Textile and its subsidiaries[21] Profit Commitments - The company committed to achieving net profits of no less than CNY 499.81 million, CNY 649.96 million, and CNY 779.48 million for the years 2015, 2016, and 2017 respectively[24] - The forecasted net profit for 2018 is set at no less than CNY 936.80 million[24] - If the actual net profit falls below the committed net profit, compensation will be calculated according to the agreed formula in the profit forecast compensation agreement[25] - The company will avoid or minimize related transactions with Tianshan Textile and its subsidiaries[25] - The company will not seek preferential treatment in business cooperation with Tianshan Textile due to its shareholder status[25] - The company will ensure that any future related transactions will follow legal decision-making procedures[25] - The company has a commitment period for profit compensation that spans from January 1, 2016, to December 31, 2018[24] - The company will not utilize its shareholder status to gain advantages over third parties in transactions with Tianshan Textile[25] - The company will not occupy Tianshan Textile's funds through loans or other means[25] - The company will ensure that all related transactions are conducted at market fair prices[25] Independence and Governance - The company is committed to maintaining independence in personnel, assets, finance, and operations, ensuring no overlap with controlling entities[27] - The restructuring plan involves acquiring assets from Jialin Pharmaceutical, with a focus on maintaining operational independence post-acquisition[28] - The company guarantees that its financial department and accounting systems are independent, with no shared bank accounts with controlling entities[28] - The company aims to minimize related party transactions and ensure they are conducted at market prices when necessary[28] - The commitment to avoid substantial competition with Jialin Pharmaceutical and its subsidiaries is emphasized, ensuring a clear operational boundary[27] - The company has established a complete and independent organizational structure to support its governance and operational integrity[28] - The management team, including senior executives, will be exclusively dedicated to the company, with no dual roles in controlling entities[28] - The company will independently make financial decisions and is committed to legal compliance in its operations[28] - The company has a long-term commitment to uphold these independence principles throughout the restructuring process[27] - The company will ensure that its business activities are conducted independently, with the capability to sustain operations in the market[28] Regulatory Compliance - 嘉林药业承诺在2017年底前办理完毕未办理权属证书的房屋,相关税费由承诺人承担[30] - 嘉林药业未因未办理权属证书的房屋受到政府相关部门的行政处罚[30] - 嘉林药业的控股股东承诺如因未办理权属证书导致经济损失,将全额承担相关费用和损失[30] - 嘉林药业在缺少建设用地手续的情况下开工建设的项目未受到相关行政监督管理部门的处罚[29] - 嘉林药业的控股股东将采取措施确保未办理权属证书的房屋不遭受损失[30] - 嘉林药业的控股股东承诺将督促公司尽快办理房屋权属证书[30] - 嘉林药业的控股股东承诺本次重组完成后,不会在分红比例等方面对上市公司造成影响[31] Leadership - The chairman of the board is Zhang Yong, indicating stable leadership during this period[39]
德展健康(000813) - 2016 Q3 - 季度财报
2016-10-30 16:00
Financial Performance - Revenue for the reporting period was ¥402,028,503.47, representing a year-on-year growth of 160.47%[7] - Net profit attributable to shareholders was ¥195,756,734.55, a significant increase of 14,569.29% compared to the same period last year[7] - Basic earnings per share (EPS) for the reporting period was ¥0.2237, up 7,613.79% year-on-year[7] - Operating cash flow for the reporting period was ¥306,988,520.79, an increase of 254.15% compared to the previous year[7] - The weighted average return on equity was 10.17%, a substantial increase from 0.13% in the previous year[7] - The company reported a net profit of ¥522,684,388.70 for the first nine months of 2016, a year-on-year increase of 36,336.51%[10] - Cash and cash equivalents increased by 204.99% to ¥352,388,550.87 due to sales growth and collection of receivables[17] - The total profit for Q3 2016 was ¥237,779,491.58, a 36.90% increase attributed to sales growth[18] - The company reported a significant asset restructuring plan, with a commitment to unlock 50% of the shares after the first year of profit compensation obligations are fulfilled[30] Asset and Equity Changes - Total assets at the end of the reporting period reached ¥2,307,916,267.64, an increase of 17.02% compared to the end of the previous year[7] - The company’s total equity attributable to shareholders increased by 99.83% to ¥2,126,005,796.61 compared to the previous year[7] - The company’s capital reserve increased by 340.65% to ¥123,466,276.40 due to significant asset restructuring[17] - Total liabilities decreased to ¥182,811,563.94 from ¥244,101,467.43, indicating a reduction of approximately 25%[54] - The company's equity attributable to shareholders rose to CNY 2,126,005,796.61, up from CNY 1,494,301,396.21, marking an increase of around 42.3%[55] Shareholder Information - Total number of common shareholders at the end of the reporting period is 22,411[13] - Xinjiang Kaidi Investment Co., Ltd. holds 30.24% of shares, totaling 141,354,457 shares[13] - Xinjiang Kaidi Mining Investment Co., Ltd. holds 28.74% of shares, totaling 134,359,578 shares, with 69,359,578 shares under lock-up[13] - The top 10 shareholders account for significant ownership, with the largest shareholder holding over 30%[15] - The top shareholder, Meilin Holdings Group, holds 27.51% of shares, totaling 369,399,114 shares[15] Asset Restructuring - The company completed a major asset restructuring on September 30, 2016, which significantly impacted financial performance[10] - The company’s strategic asset restructuring involved the transfer of assets and equity to enhance operational efficiency and market position[10] - The company completed the transfer and registration of assets related to the major asset restructuring by September 28, 2016[23] - The company issued 875,168,898 shares to various shareholders, resulting in a 27.51% ownership stake by Meilin Holdings, making it the controlling shareholder[24] - The company received unconditional approval from the China Securities Regulatory Commission for its major asset restructuring on July 22, 2016[21] Compliance and Governance - The company committed to strictly adhere to the requirements of the China Securities Regulatory Commission regarding the independent governance structure of listed companies, fulfilling this commitment as of the announcement date[28] - The company guarantees that it and its subsidiaries will not engage in the same business activities as Tianshan Textile to maintain operational independence[29] - The company has committed to not providing unfair benefits to other entities or individuals, ensuring the integrity of its operations[29] - The company has pledged to maintain the independence of its personnel, assets, finances, and operations, ensuring no mixing with related parties[32] - The company will disclose information regarding future related transactions in accordance with the Shenzhen Stock Exchange's regulations[32] Future Outlook and Growth - The company provided a positive outlook for Q4 2016, projecting a revenue increase of 10% to 12%[37] - New product launches are expected to contribute an additional $5 million in revenue for the upcoming quarter[38] - The company is expanding its market presence in Southeast Asia, targeting a 25% market share by the end of 2017[37] - Research and development investments increased by 30% in 2016, focusing on innovative health solutions[38] - The estimated cumulative net profit for the year is projected to be between CNY 650.32 million and CNY 713.36 million, representing a significant increase of 615.96% to 1,148.13% compared to the previous year[42] Legal and Regulatory Compliance - The company has fully complied with laws and regulations in production and operation over the past five years, with no significant violations or penalties[36] - The company is in compliance with environmental regulations and has not faced any significant penalties or complaints related to environmental issues[41] - 嘉林药业在2016年第三季度报告中未发生重大违法违规行为,符合国家及地方安全生产法律法规[39] - The company has not engaged in any illegal asset transfers or concealment of assets related to Beijing Jialin Pharmaceutical Co., Ltd.[36] - The company has no ongoing or foreseeable significant litigation or administrative penalty cases that could harm investor rights[36]
德展健康(000813) - 2016 Q2 - 季度财报
2016-08-26 16:00
Financial Performance - The company's operating revenue for the first half of 2016 was ¥190,662,689.51, a decrease of 20.78% compared to ¥240,659,925.75 in the same period last year[21]. - The net profit attributable to shareholders of the listed company was a loss of ¥22,138,946.53, a decline of 496.28% from a profit of ¥5,586,652.28 in the previous year[21]. - Basic earnings per share were reported at -¥0.0474, a decrease of 495.00% compared to ¥0.0120 in the same period last year[21]. - The total operating revenue for the first half of 2016 was CNY 190,662,689.51, a decrease of 20.8% compared to CNY 240,659,925.75 in the same period of 2015[123]. - The total operating costs amounted to CNY 200,711,691.22, slightly down from CNY 204,771,645.10, resulting in an operating loss of CNY -8,507,300.41 compared to a profit of CNY 35,888,280.65 in the previous year[123]. - The company reported a total comprehensive loss of CNY 42,570,123.20, compared to a loss of CNY 29,843,883.15 in the previous period[128]. Cash Flow and Liquidity - The net cash flow from operating activities increased by 129.38% to ¥42,781,351.32, compared to ¥18,650,883.54 in the same period last year[21]. - The total cash inflow from operating activities was CNY 251,727,296.38, a decrease of 6.8% compared to CNY 270,154,586.62 in the previous period[130]. - The cash and cash equivalents at the end of the period stood at CNY 145,770,606.97, compared to CNY 91,203,706.93, reflecting a significant increase of 60%[132]. - The total cash outflow for investment activities was CNY 41,712,134.74, up from CNY 19,205,699.00, indicating a rise of 117%[131]. - The net cash flow from investment activities was CNY -37,988,643.13, worsening from CNY -18,179,699.00 in the previous period[131]. Assets and Liabilities - The total assets at the end of the reporting period were ¥1,990,272,143.12, reflecting a slight increase of 0.91% from ¥1,972,266,539.18 at the end of the previous year[21]. - The total liabilities amounted to CNY 632,867,104.14, up from CNY 599,395,638.93, which is an increase of approximately 5.6%[115]. - The company's equity totaled CNY 1,357,405,038.98, down from CNY 1,372,870,900.25, reflecting a decrease of about 1.1%[116]. - Current assets totaled CNY 372,538,434.81 at the end of the reporting period, up from CNY 366,417,749.58, indicating a growth of about 1.2%[114]. - The company's total assets decreased to CNY 1,324,072,455.39 from CNY 1,382,802,527.64, indicating a reduction of approximately 4.2%[120]. Shareholder Information - The total number of shares outstanding is 467,495,300, with 22.26% being restricted shares and 77.74% being unrestricted shares[95]. - The largest shareholder, Xinjiang Kaidi Investment Co., Ltd., holds 30.24% of the shares, totaling 141,354,457 ordinary shares[97]. - The total number of shareholders at the end of the reporting period is 19,647[97]. - The company has not reported any changes in the number of shares or shareholder structure that would affect earnings per share or net asset value per share[95]. Governance and Compliance - The company has a well-structured governance system, including a board of directors with 9 members, 3 of whom are independent directors[59]. - The company has maintained its independence and governance structure as per regulatory requirements[82]. - The financial report does not include any commitments regarding future plans or development strategies, highlighting the need for investors to be aware of investment risks[6]. - The half-year financial report was not audited[85]. Business Operations - The textile segment generated operating revenue of CNY 76.08 million, with a gross margin of 10.00%, while the mining segment reported CNY 109.73 million in revenue, with a gross margin of 39.63%[34]. - The company completed the relocation of its textile subsidiary to the Tianshan Textile Industrial Park, which is now fully operational[33]. - The mining division has completed 60.91% of the deep mining project and has made significant progress in the filling system project[33]. - Domestic sales increased by 32.11% to CNY 157.60 million, while foreign sales rose by 1.70% to CNY 28.59 million[37]. Investment and Restructuring - The company completed a major asset restructuring, exchanging assets valued at 798.75 million with Merrylin Holdings for a 47.72% stake in Jialin Pharmaceutical[88]. - The restructuring was approved by the China Securities Regulatory Commission (CSRC) on July 29, 2016[90]. - The company has received approval for its major asset restructuring from the Xinjiang State-owned Assets Supervision and Administration Commission and the China Securities Regulatory Commission[29]. Research and Development - Research and development expenses decreased by 67.11% to CNY 221,779, reflecting a reduction in investment in this area[31]. - The company has not conducted any research, communication, or interview activities during the reporting period[56]. Risk Management - The company has established a hedging system for futures trading to mitigate price fluctuation risks[46]. - The company has implemented strict internal controls and management for its hedging activities to ensure compliance with regulations[46].
德展健康(000813) - 2016 Q1 - 季度财报
2016-04-27 16:00
Financial Performance - The company's operating revenue for Q1 2016 was ¥71,597,342.99, a decrease of 44.22% compared to ¥128,350,852.98 in the same period last year[8] - The net profit attributable to shareholders was a loss of ¥9,406,394.02, representing a decline of 282.66% from a profit of ¥5,149,675.22 in the previous year[8] - The net profit attributable to shareholders after deducting non-recurring gains and losses was a loss of ¥10,219,181.03, down 346.48% from ¥4,146,093.27 in the same period last year[8] - The net cash flow from operating activities was ¥14,200,550.62, a decrease of 42.16% compared to ¥24,551,346.83 in the previous year[8] - The basic and diluted earnings per share were both -¥0.0201, a decline of 301.00% from ¥0.0100 in the same period last year[8] - The weighted average return on equity was -0.89%, down 1.38% from 0.49% in the previous year[8] - The company reported a significant decline in net profit, resulting in a comprehensive income total of -¥7,135,477.08, down 165.78% from ¥10,846,737.60[15] Assets and Shareholder Information - Total assets at the end of the reporting period were ¥1,972,415,956.95, a slight increase of 0.01% from ¥1,972,266,539.18 at the end of the previous year[8] - The net assets attributable to shareholders were ¥1,055,668,403.76, a decrease of 0.78% from ¥1,063,921,536.94 at the end of the previous year[8] - The total number of ordinary shareholders at the end of the reporting period was 22,396[11] - The largest shareholder, Xinjiang Kaidi Investment Co., Ltd., held 30.24% of the shares, while the second largest, Xinjiang Kaidi Mining Investment Co., Ltd., held 28.74%[11] Operating Costs and Cash Flow - The company's operating costs also fell by 34.68% to ¥54,538,879.21 from ¥83,493,749.41 year-over-year[15] - The net cash flow from operating activities decreased by 42.16% to ¥14,200,550.62, primarily due to reduced revenue[15] - The company’s employee compensation payable decreased by 34.71% to ¥9,650,033.96, due to salary payments made during the period[15] - The company’s tax expenses dropped by 77.96% to ¥2,836,933.97, reflecting a decrease in net profit[15] Investment and Financing Activities - The company’s investment activities cash outflow increased by 55.87% to ¥15,209,928.53, attributed to payments for construction projects[16] - The company’s financing activities cash inflow decreased by 84.15% to ¥863,387.51, reflecting a reduction in bank loans obtained[16] Corporate Governance and Compliance - The company is undergoing a major asset restructuring, involving asset swaps and a total fundraising amount not exceeding ¥150,948.88 million[17] - The company has committed to not engaging in any activities that would harm the interests of its shareholders, maintaining compliance with its commitments[18] - The company reported a significant focus on maintaining transparency and fairness in related party transactions to protect shareholder interests[19] - The company has committed to ensuring independence from its controlling shareholders and avoiding business competition with them[20] - The company is committed to adhering to regulatory requirements set by the China Securities Regulatory Commission regarding corporate governance[21] - The company has established a lock-up period for newly issued shares, which will last for 36 months or until the final profit compensation decision, whichever is longer[20] - The company has made promises to avoid unfair benefit transfers to other parties and to ensure proper conduct by its directors and senior management[20] Risk Management and Hedging Activities - The company reported a loss of 263,000 CNY from copper futures contracts in Q1 2016[25] - The fair value of the company's copper futures contracts was determined based on quotes from the Shanghai Futures Exchange[25] - The company began conducting hedging activities for copper and zinc metals during the reporting period[25] - The company strictly controls the scale of hedging funds and plans the use of margin according to internal regulations[25] - The company has established a hedging system to mitigate price fluctuation risks associated with copper, zinc, gold, and silver products[25] - The company emphasizes that the risks associated with its hedging activities are manageable and necessary for stable operational performance[25] - The company’s hedging activities are aligned with its production operations and are limited to domestic futures exchanges[25] Other Activities and Commitments - The company has not engaged in any securities investments during the reporting period[22] - The company has not forecasted any significant changes in net profit for the first half of 2016 compared to the previous year[22] - The company has not reported any derivative investments during the reporting period[23] - No non-operating fund occupation by controlling shareholders or related parties was reported during the period[28] - The company did not engage in any external guarantees that violate regulations during the reporting period[27] - There were no research, communication, or interview activities conducted during the reporting period[26]
德展健康(000813) - 2015 Q4 - 年度财报
2016-03-13 16:00
Asset Restructuring - The company reported a significant asset restructuring involving the exchange of assets valued at 798.75 million RMB with Meilin Holdings for a 47.72% stake in Jialin Pharmaceutical[10]. - The total cash consideration for the remaining assets sold to the controlling shareholder Kaidi Investment amounted to 118.79 million RMB[10]. - The company plans to raise up to 1.51 billion RMB in supporting funds as part of the asset restructuring process[10]. - The company emphasizes the importance of regulatory approvals for the asset restructuring, which introduces uncertainty regarding completion timelines[4]. - The company is actively pursuing a major asset restructuring, planning to acquire 100% equity of Jialin Pharmaceutical through asset swaps and share issuance[130]. - The restructuring process involves independent financial advisors, auditing firms, and legal consultants to ensure compliance with regulations[131]. - The company has received approval from its board and shareholders for the restructuring plan, which is pending approval from the China Securities Regulatory Commission[131]. - The company is undergoing a major asset restructuring, which includes a plan for employee stock ownership[114]. Financial Performance - The company's operating revenue for 2015 was ¥510,772,749.97, a decrease of 8.69% compared to ¥559,371,797.43 in 2014[20]. - The net profit attributable to shareholders for 2015 was ¥6,159,630.04, representing a significant decline of 71.36% from ¥21,503,636.62 in 2014[20]. - The net profit after deducting non-recurring gains and losses was -¥5,344,922.24 in 2015, a decrease of 393.98% compared to ¥1,818,154.47 in 2014[20]. - The net cash flow from operating activities was ¥124,913,816.49, down 8.46% from ¥136,465,461.46 in 2014[20]. - The total assets at the end of 2015 were ¥1,972,266,539.18, a decrease of 2.93% from ¥2,031,724,038.69 at the end of 2014[20]. - The net assets attributable to shareholders increased slightly to ¥1,063,921,536.94, up 0.66% from ¥1,056,951,110.07 in 2014[20]. - The basic earnings per share for 2015 were ¥0.01, down 80.00% from ¥0.05 in 2014[20]. - The diluted earnings per share also stood at ¥0.01, reflecting the same 80.00% decrease compared to the previous year[20]. - The weighted average return on equity was 0.58% in 2015, down from 2.06% in 2014, indicating a decline in profitability[20]. - The company reported a total of ¥11,504,552.28 in non-recurring gains for 2015, compared to ¥19,685,482.15 in 2014[26]. Business Segments - The company produced 25,314 tons of copper concentrate and 29,986 tons of zinc concentrate in 2015, with sales revenue of 304.51 million yuan and a net profit of 108.98 million yuan[29]. - The textile business achieved sales of 740,000 garments in 2015, an increase of 43,600 garments year-on-year, generating sales revenue of 191.10 million yuan, but incurred a net loss of 29.40 million yuan[31]. - Mining sector revenue was CNY 304.51 million, accounting for 59.61% of total revenue, with a year-on-year decrease of 11.27%[46]. - Textile sector revenue was CNY 191.10 million, representing 37.41% of total revenue, down 6.81% year-on-year[46]. - The company plans to undergo a major asset restructuring to divest its textile and mining businesses, aiming to enhance its profitability by entering the rapidly growing pharmaceutical market[33]. Cash Flow and Investments - Operating cash inflow decreased by 11.73% to approximately $601.95 million in 2015 compared to $681.91 million in 2014[63]. - Operating cash outflow decreased by 12.54% to approximately $477.03 million in 2015 compared to $545.45 million in 2014[63]. - Net cash flow from investment activities improved by 28.78%, with a net outflow of approximately $57.63 million in 2015 compared to $80.93 million in 2014[63]. - Financing cash outflow increased by 40.51% to approximately $346.91 million in 2015 compared to $246.89 million in 2014, primarily due to increased loan repayments[64]. - The company is seeking a credit line of 400 million yuan from multiple banks to support raw material procurement and working capital needs in 2016[86]. Shareholder Returns and Dividends - No cash dividends or stock bonuses will be distributed to shareholders for the year[5]. - The company did not propose any cash dividends for 2015 due to accumulated undistributed profits being negative at -703,990,938.87 CNY[96]. - The independent directors agreed with the decision not to distribute cash dividends for 2015, citing compliance with the company's articles of association[96]. - The company has not distributed any cash dividends in the past three years (2013-2015), maintaining a 0.00% payout ratio[99]. - The board plans to review the shareholder return plan at least once every three years, considering operational performance and investment needs[95]. Governance and Compliance - The company’s financial report is guaranteed to be true, accurate, and complete by its board and management[3]. - The company has established a commitment to ensure fair and transparent related-party transactions to protect shareholder interests[101]. - The company has a long-term commitment to comply with the regulatory requirements for maintaining a sound corporate governance structure[101]. - The company has established a strong governance structure with independent directors to ensure compliance and accountability[154]. - The internal control system has been evaluated with no significant defects reported during the period[184]. Market and Economic Conditions - The company faces risks from domestic and international market fluctuations, with a significant slowdown in domestic demand growth anticipated in 2016[82]. - The company’s textile business relies heavily on exports, with over 50% of revenue coming from foreign sales, making it vulnerable to exchange rate fluctuations[83]. - Rising production costs are anticipated in 2016 due to a slowdown in the textile industry and increased fixed costs from new industrial park operations[83]. Future Outlook and Strategy - The company plans to enhance its technological capabilities and promote resource sharing among members of the Xinjiang Textile Industry Technology Innovation Strategic Alliance[39]. - The company aims to stabilize production capacity and improve labor efficiency through reasonable job adjustments[81]. - The company plans to enhance its sales strategy by integrating domestic and foreign sales operations, focusing on brand transformation and e-commerce growth[85]. - Future guidance indicates a revenue growth target of 12% for 2016, driven by new product launches and market expansion efforts[157]. Employee and Management Information - The company reported a total of 7,000 employees as of 2015, maintaining the same number since 2010[151]. - The total remuneration for directors, supervisors, and senior management during the reporting period amounted to 2,257,400 CNY[158]. - The average salary for senior management was 311,800 CNY per person[163]. - The average salary for all employees was 81,700 CNY per person[163]. - The management team is focused on expanding the company's market reach and exploring new investment opportunities in the textile industry[154].
德展健康(000813) - 2015 Q3 - 季度财报
2015-10-27 16:00
Financial Performance - Net profit attributable to shareholders was CNY 1,334,466.77, down 94.83% year-on-year[6]. - Operating revenue for the reporting period was CNY 154,344,755.46, a decrease of 19.77% compared to the same period last year[6]. - Basic earnings per share were CNY 0.0029, down 94.75% year-on-year[6]. - Operating profit decreased by 39.59% to ¥49,092,164 from ¥81,267,151 primarily due to increased asset impairment losses[14]. - Net profit attributable to the parent company decreased by 83.31% to ¥6,921,119 from ¥41,459,159 due to increased asset impairment losses and reduced government subsidies[14]. - Net profit for the current period is ¥24,741,407.60, a decline of 59.9% compared to ¥61,786,664.38 in the previous period[48]. - The net profit attributable to the parent company is ¥6,921,119.05, down 83.3% from ¥41,459,159.27 in the previous period[48]. - The company reported a comprehensive income total of CNY 8,146,617.26, a decrease of 78.6% from CNY 38,001,107.94 in the previous period[41]. Cash Flow - The net cash flow from operating activities decreased by 39.26% to CNY 86,684,394.90 year-to-date[6]. - Cash flow from operating activities decreased by 39.26% to ¥86,684,394 from ¥142,720,304 mainly due to increased tax payments[14]. - The net cash flow from operating activities for Q3 2015 was ¥86,684,394.90, a decrease of 39.3% compared to ¥142,720,304.51 in Q3 2014[55]. - Total cash inflow from operating activities was ¥484,451,387.59, while cash outflow was ¥397,766,992.69, resulting in a net cash inflow of ¥86,684,394.90[55]. - The total cash outflow from operating activities was ¥397,766,992.69, which is an increase from ¥379,964,378.30 in Q3 2014[55]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 2,015,447,852.09, a decrease of 0.80% compared to the end of the previous year[6]. - Current assets totaled CNY 435,419,323.48, down from CNY 444,673,240.91 at the beginning of the period, reflecting a decrease of approximately 2.83%[31]. - Total liabilities decreased to CNY 636,950,978.00 from CNY 679,746,351.09, a reduction of approximately 6.3%[33]. - Total liabilities amount to CNY 463,098,441.47, an increase from CNY 428,115,765.12 in the previous period[40]. - The company's equity attributable to shareholders increased to CNY 1,065,650,008.01 from CNY 1,056,951,110.07, reflecting a growth of about 0.7%[34]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 20,698[10]. - Xinjiang Kaidi Investment Co., Ltd. held 30.24% of shares, making it the largest shareholder[10]. Government Subsidies and Other Income - The company received government subsidies amounting to CNY 5,017,936.72 during the reporting period[7]. - The company reported a significant decline in net profit due to non-recurring losses, with a net profit excluding non-recurring items at CNY -1,959,024.81[6]. Asset Restructuring - The company plans to conduct a major asset restructuring involving the acquisition of Beijing Jialin Pharmaceutical Co., Ltd. through asset swaps and share issuance[17]. - The restructuring process includes hiring independent financial advisors and conducting due diligence on the target assets[17]. - The company has been actively communicating with stakeholders regarding the restructuring and has filed necessary disclosures as per regulatory requirements[17]. - The company’s stock was suspended multiple times during the restructuring process, indicating ongoing negotiations and evaluations[16]. Commitments and Compliance - The company has committed to maintaining independence and avoiding unnecessary related transactions with its controlling entities, ensuring fairness and transparency in transactions[20]. - The company has pledged to gradually standardize financial accounting and management practices at Qinghai Xuechi, with annual audits by a qualified accounting firm[21]. - The company has made commitments to avoid competition with its subsidiaries in the same market to maintain operational independence[21]. - The company has established a profit compensation mechanism for any shortfall in actual profits compared to forecasted profits from its mining assets[21]. - The company has committed to prioritizing investment opportunities in mining assets for the listed company, ensuring compliance with relevant commitments[21]. - The company has confirmed that all commitments made are being fulfilled in a timely manner[22]. Other Financial Metrics - The weighted average return on net assets was 0.13%, a decrease of 2.29% compared to the previous year[6]. - The company reported no derivative investments or non-compliance with external guarantees during the reporting period[25][27]. - There are no securities investments reported during the reporting period[22].
德展健康(000813) - 2015 Q2 - 季度财报
2015-08-28 16:00
Financial Performance - The company's operating revenue for the first half of 2015 was CNY 240,659,925.75, representing a 12.28% increase compared to CNY 214,331,444.12 in the same period last year[20]. - Net profit attributable to shareholders decreased by 64.34% to CNY 5,586,652.28 from CNY 14,149,740.15 in the previous year[20]. - The net cash flow from operating activities fell by 70.38% to CNY 18,650,883.54, down from CNY 62,976,507.89 in the same period last year[20]. - Basic and diluted earnings per share decreased by 64.18% to CNY 0.0120 from CNY 0.0303 in the previous year[20]. - The weighted average return on net assets decreased to 0.53% from 1.24% in the previous year[20]. - The company achieved an operating income of CNY 240,659.93 million, an increase of 12.28% year-on-year[30]. - The net profit attributable to shareholders was CNY 558.67 million, a decrease of 64.34% compared to the previous year[29]. - The total operating revenue for the first half of 2015 was CNY 240,659,925.75, an increase of 12.0% compared to CNY 214,331,444.12 in the same period of 2014[113]. - The total operating costs amounted to CNY 204,771,645.10, up from CNY 188,683,140.77, reflecting a growth of 8.5%[113]. - The company recorded a total comprehensive income of CNY 16,468,638.48, down from CNY 23,963,152.36 in the same period last year[114]. Asset and Equity Changes - Total assets at the end of the reporting period were CNY 1,968,559,737.94, a decrease of 3.11% from CNY 2,031,724,038.69 at the end of the previous year[20]. - Net assets attributable to shareholders increased by 0.55% to CNY 1,062,731,275.24 from CNY 1,056,951,110.07 at the end of the previous year[20]. - The company's total assets as of June 30, 2015, were CNY 196,855.97 million, a decrease of 3.11% compared to the same period last year[29]. - The company's current assets totaled CNY 383,119,217.11, down from CNY 444,673,240.91 at the beginning of the period, indicating a decline of approximately 13.8%[104]. - The company's total equity attributable to the parent company was CNY 903,218,197.78, a decrease from CNY 933,062,080.93[110]. - The total owner's equity at the end of the current period is 1,351,977,687.00 CNY[132]. Cash Flow and Financing Activities - The net cash flow from operating activities was CNY 18,650,883.54, down 70.4% from CNY 62,976,507.89 in the previous period[121]. - The company reported a net cash flow from financing activities of CNY -57,452,066.45, a significant decline from CNY 63,360,624.95 in the previous period[122]. - The total cash inflow from investment activities was 23,526,000.00 CNY, while cash outflow was 21,862,992.95 CNY[125]. - The cash and cash equivalents decreased significantly to CNY 34,220,680.24 from CNY 65,669,951.25, a decline of 47.9%[108]. - The company received 154,563,862.03 CNY from borrowings during the period, slightly down from 158,368,648.58 CNY in the previous period[125]. Dividends and Shareholder Actions - The company plans not to distribute cash dividends or issue bonus shares for this reporting period[5]. - The company does not plan to distribute cash dividends or issue new shares from capital reserves for the reporting period[53]. - There were no plans for share repurchase or increase in shareholding by major shareholders during the reporting period[92]. Subsidiaries and Investments - The company holds a 8.78% stake in Xinjiang Jin Xin Trust Company, with an initial investment of ¥65,000,000 and a total of 50,000,000 shares at the end of the reporting period[39]. - The company reported a total revenue of ¥695,244,090 and a net profit of ¥65,681,095.1 for its subsidiary Xinjiang Xituo Mining Co., Ltd[48]. - The company’s subsidiary Zhejiang Tianshan Cashmere Products Co., Ltd reported a net loss of ¥2,485,090 with total assets of ¥75,310,198[48]. - The company has invested ¥1,228,000 in the Tianshan Textile Industrial Park project, with a total planned investment of ¥25,000,000, and the project is currently at 99% completion[51]. - The company’s subsidiary Xinjiang Tianfarm Animal Husbandry Technology Development Co., Ltd reported a net loss of ¥1,478,584.19 with total assets of ¥26,950,860[48]. Corporate Governance and Compliance - The governance structure complies with the Company Law and relevant regulations, with a board consisting of 9 members, including 3 independent directors[56][57]. - The company has made commitments to avoid conflicts of interest and ensure fair related transactions[77]. - The company has committed to maintaining its independence and adhering to the regulatory requirements set by the China Securities Regulatory Commission[79]. - The company has not faced any penalties or rectification issues during the reporting period[81]. - The company has not engaged in any asset acquisitions or sales during the reporting period[61][62]. Strategic Developments - The company is undergoing a major asset restructuring, which currently has uncertainties[5]. - The company is actively pursuing a major asset restructuring, which includes issuing shares to acquire equity in a target company primarily engaged in pharmaceutical product development, production, and sales[84]. - The restructuring plan is currently under negotiation and verification, with specific transaction details being discussed[84]. - The company has engaged independent financial, legal, auditing, and evaluation advisors to facilitate the due diligence and assessment of the target assets for the restructuring[84]. Market and Sales Performance - Domestic sales increased by 43.13% to CNY 208,946.79 million, while foreign sales decreased by 19.18%[35]. - The textile segment's operating income decreased by 22.77%, while the mining segment's operating income increased by 31.59%[33]. Financial Reporting and Audits - The financial report for the first half of 2015 was not audited[101]. - The company has not completed any audits for the semi-annual financial report[80]. Miscellaneous - There were no major litigation or arbitration matters during the reporting period[58]. - The company has not implemented any equity incentive plans during the reporting period[64]. - The company has no media controversies or bankruptcy restructuring matters during the reporting period[59][60].
德展健康(000813) - 2015 Q1 - 季度财报
2015-04-28 16:00
新疆天山毛纺织股份有限公司 2015 年第一季度报告正文 证券代码:000813 证券简称:天山纺织 公告编号:2015-010 新疆天山毛纺织股份有限公司 2015 年第一季度报告正文 1 新疆天山毛纺织股份有限公司 2015 年第一季度报告正文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整,不存在虚假记载、误导性陈述或者重大遗漏,并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人武宪章、主管会计工作负责人赵梅及会计机构负责人(会计主管 人员)侯毓宏声明:保证季度报告中财务报表的真实、准确、完整。 2 新疆天山毛纺织股份有限公司 2015 年第一季度报告正文 非经常性损益项目和金额 √ 适用 □ 不适用 单位:元 | 项目 | 年初至报告期期末金额 | 说明 | | --- | --- | --- | | 非流动资产处置损益(包括已计提资产减值准备的冲销部分) | 6,260.00 | | | 计入当期损益的政府补助(与企业业务密切相关,按照国家统 | 997,321.95 | | | 一标准定额或定量享受的政府补助 ...
德展健康(000813) - 2014 Q4 - 年度财报
2015-03-23 16:00
Financial Performance - In 2014, the company achieved operating revenue of CNY 559,371,797.43, a decrease of 1.72% compared to CNY 569,175,768.99 in 2013[23]. - The net profit attributable to shareholders was CNY 21,503,636.62, representing a decline of 26.61% from CNY 29,299,944.24 in the previous year[23]. - The company's total assets increased by 6.89% to CNY 2,031,724,038 compared to CNY 1,900,505,478 at the end of 2013[23]. - The net cash flow from operating activities was CNY 136,465,461.46, down 20.00% from CNY 170,585,210.11 in 2013[23]. - The company reported a basic earnings per share of CNY 0.05, a decrease of 28.57% from CNY 0.07 in the previous year[23]. - The company's main business revenue decreased by 1.72% compared to last year, with textile revenue down by 0.6% and mining revenue down by 1.89%[33]. - The company reported a net profit attributable to shareholders of 21,503,636.62 yuan for the year 2014, with a net profit margin of 0.00% for cash dividends[97]. - The company did not distribute any cash dividends for 2014, 2013, and 2012, as the net profits were used to offset previous losses, resulting in a cumulative undistributed profit of -692,313,967.93 yuan by the end of 2014[99]. Shareholder Structure - As of December 11, 2014, the company’s major shareholder, Kaidi Investment, held 30.24% of the total shares, while Kaidi Mining held 28.74%[18]. - The total number of shares after the recent changes is 467,495,367, with 66.40% being restricted shares and 33.60% being unrestricted shares[138]. - The shareholding structure shows that Kaidi Investment holds 30.24% (141,354,457 shares) and Kaidi Mining holds 28.74% (134,359,578 shares) after the transfer of 65 million shares[139]. - The number of restricted shares decreased by 206,349,240, while unrestricted shares increased by the same amount, reflecting a significant shift in ownership[138]. - The company has a total of 310,393,824 restricted shares, with 206,354,457 shares released during the reporting period[141]. - The shareholding of Qinghai Xuechi Technology Co., Ltd. remains at 7.42% (34,679,789 shares) with no changes during the period[145]. Corporate Governance - The company has a total of 2,071 employees eligible for post-employment benefits, including 1,115 active employees, 783 retired employees, and 173 employees on early retirement[89]. - The company has a total of 1,320 employees, with 783 retirees for whom the company bears medical insurance costs[169]. - The company has a training plan for 2015 that includes ISO29001 and ISO14001 internal auditor qualification training, as well as various management and technical training programs[169]. - The board of directors consists of 9 members, including 3 independent directors, ensuring a majority of independent representation in committees[173]. - The company has established a system for insider information management to prevent insider trading, with no reported violations during the reporting period[178]. - The independent directors actively participated in training sessions to enhance corporate governance knowledge and practices[176]. - The company maintains complete independence from its controlling shareholder in business, personnel, assets, and finance[190]. - The company has committed to avoiding competition with its controlling shareholder in the same sales market[192]. Strategic Plans and Future Outlook - The company aims to leverage the "Belt and Road" initiative to enhance its competitive edge and explore strategic partnerships[54]. - The company plans to maintain a sustainable and stable shareholder return policy while considering operational performance and future profitability[99]. - The company aims to enhance its textile business by establishing a textile division and a new textile and apparel company, consolidating all textile assets and operations[76]. - The company will focus on expanding its market presence by increasing cooperation with international clothing brands and enhancing product quality to boost export sales[76]. - Future guidance estimates a revenue growth of 12% for 2015, driven by new product launches and market expansion[160]. - The company plans to implement a three-year shareholder return plan from 2014 to 2016, which was approved in the first extraordinary general meeting of 2014[180]. Operational Performance - The mining segment exceeded operational targets through systematic upgrades and enhanced mining capabilities[30]. - The company completed the integration of its wool textile production and sales system, optimizing internal structure and management[31]. - The company is focusing on optimizing its textile industry structure and enhancing its operational efficiency through internal reforms and strategic collaborations[54]. - The company has initiated discussions for potential mergers with two local textile firms to enhance production capacity[160]. - The company aims to reduce operational costs by 5% through improved supply chain management in 2015[160]. Financial Management and Accounting - The company adopted new accounting standards effective July 1, 2014, including the revised Accounting Standard No. 2 for Long-term Equity Investments, resulting in a decrease of CNY 65 million in long-term equity investments[90]. - The company has implemented retrospective adjustments for accounting policy changes, affecting various financial statement items, including a decrease of CNY 101,971,886.81 in retained earnings[90]. - The company’s financial statements have been adjusted to comply with the revised Accounting Standard No. 30, affecting other comprehensive income[90]. - The audit committee confirmed that the 2014 financial report accurately reflects the company's overall situation and approved the appointment of the auditing firm for 2015[186]. Social Responsibility and Compliance - The company has complied with environmental regulations and maintained stable pollutant discharge standards[102]. - The company has actively engaged in social responsibility initiatives, including safety management and environmental protection measures[102]. - The company has not reported any non-operating fund occupation by controlling shareholders or related parties during the reporting period[106]. - The company has not faced any significant litigation or arbitration matters during the reporting period[104]. Employee and Management Changes - The company appointed Zhao Mei as the financial director on January 20, 2014, following the resignation of the previous financial director[166]. - Zhang Zhan resigned from the board of directors on August 18, 2014, due to work-related reasons[166]. - The company appointed Yu Xiong Lai and Wei Zhe Ming as deputy general managers on January 20, 2014[166]. - The total remuneration for directors, supervisors, and senior management during the reporting period amounted to CNY 315.66 million[164].
德展健康(000813) - 2014 Q3 - 季度财报
2014-10-22 16:00
Financial Performance - Total assets at the end of the reporting period reached ¥2,039,030,980.15, an increase of 7.29% compared to the previous year[7] - Net profit attributable to shareholders was ¥25,036,703.65, representing a significant increase of 274.30% year-on-year[7] - Operating revenue for the period was ¥192,368,165.81, reflecting a growth of 16.28% compared to the same period last year[7] - Basic earnings per share increased to ¥0.0536, up 245.81% from the previous year[7] - The weighted average return on net assets was 2.15%, an increase of 186.67% year-on-year[7] - The company reported a net profit of ¥39,186,443.80 for the year-to-date, which is a 95.12% increase compared to the same period last year[7] - Net profit attributable to the parent company increased by 95.12% to ¥39,186,443.80, driven by an increase in the consolidation ratio of Xituo Mining[14] Cash Flow and Financial Position - The net cash flow from operating activities for the year-to-date was ¥142,720,304.51, down 7.07% compared to the previous year[7] - Cash and cash equivalents increased by 238.60% to ¥176,914,369.92 due to an increase in short-term loans[14] - Short-term borrowings rose by 67.89% to ¥189,714,859.96, reflecting an increase in working capital loans[14] - Financial expenses decreased by 41.39% to ¥11,766,453.33, due to the repayment of long-term loans[14] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 25,098[10] - The largest shareholder, Xinjiang Kaidi Investment Co., Ltd., held 44.14% of the shares, totaling 206,354,457 shares[10] Non-Recurring Items - Non-recurring gains and losses included government subsidies amounting to ¥14,705,050.76[8] - Operating income from non-operating activities surged by 329.53% to ¥14,719,014.02, attributed to government subsidies received[14] - Tax refunds received increased by 132.51% to ¥7,288,898.19, resulting from the receipt of all tax refunds for the year 2013[14] Asset Management - Prepayments increased by 111.20% to ¥66,054,183.71, primarily due to increased advance payments from Xituo Mining[14] - Other receivables increased by 55.02% to ¥9,553,616.90, indicating an increase in other receivables[14] - Asset impairment losses rose by 57.06% to ¥8,444,490.97, mainly due to changes in accounting estimates increasing bad debt provisions[14] Future Projections and Commitments - The forecasted net profit for 2013 is 68.85 million CNY, for 2014 is 100.11 million CNY, and for 2015 is 100.11 million CNY[19] - The cumulative actual profit for the three years (2013, 2014, and 2015) attributed to the listed company is projected to be 51.64 million CNY, 75.08 million CNY, and 75.08 million CNY respectively[19] - The company has committed to compensating for any shortfall in actual profits compared to the forecasted profits for the relevant assets[19] - The company has made a commitment to gradually standardize the financial accounting and management of Qinghai Xuechi, with annual audits by a qualified accounting firm[19] Corporate Governance and Compliance - The company has committed to maintaining the independence of its operations and avoiding competition with its subsidiaries[18] - The company has established a long-term commitment to avoid related party transactions that could harm the interests of shareholders[18] - The company has a commitment to ensure compliance with regulatory requirements regarding corporate governance[18] - The company has a commitment to prioritize investment opportunities in mining assets for the listed company[18] Company Activities and Strategy - The company held a research and communication event on September 25, 2014, discussing its development history and basic situation[23] - The chairman addressed national support policies and local employment issues in Xinjiang during the meeting[23] - The company emphasized its wool textile product branding and marketing strategies[23] - Post-restructuring, the company is focusing on mining development[23]